Liu · Journal of the National Cancer Institute 1994 · in vitro cell culture study · n=?

Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity.

Cited 129 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

In vitro cell culture and biochemical mechanistic study

PubMed 7966413 · doi:10.1093/jnci/86.23.1758 · record verified 2026-08-30

What was done

Researchers evaluated the induction of CYP1A1 activity (measured via ethoxyresorufin O-deethylase [EROD] activity) and antiestrogenic actions of indolo[3,2-b]carbazole (ICZ), an acid-derived condensation product of indole-3-carbinol (I3C), in MCF-7 human breast cancer cells. They assessed occupied nuclear estrogen receptor (ER) levels, 17 beta-estradiol (E2)-induced cell proliferation, [3H]thymidine uptake, secretion of the 52-kd protein, nuclear progesterone receptor (PR) levels, and chloramphenicol acetyl transferase (CAT) reporter activity using an estrogen-responsive vit-CAT plasmid. Competitive binding assays with rat cytosolic ER and gel shift assays for estrogen-responsive elements were also performed.

What was found

ICZ induced CYP1A1 at concentrations of 10 nM or greater in MCF-7 cells. ICZ inhibited E2-induced proliferation, [3H]thymidine uptake, nuclear PR binding, and vit-CAT reporter activity. In nuclear extracts, ICZ decreased ER levels and ER binding to estrogen-responsive elements; I3C similarly reduced nuclear ER binding. Antiestrogenic effects occurred at time points and concentrations where EROD activity was unchanged. ICZ also bound rat cytosolic ER with low affinity and demonstrated weak intrinsic estrogen-like activity. Exact numerical values were not reported in the abstract.

Why it matters

This study provides mechanistic evidence that dietary cruciferous vegetable derivatives can modulate estrogen signaling via aryl hydrocarbon receptor crosstalk, operating through pathways independent of cytochrome P450 hormone metabolism.

Limits

The study is restricted to in vitro assays in a single human breast cancer cell line (MCF-7) and rat cytosolic preparations. It does not measure in vivo pharmacokinetics, tissue distribution, physiological exposure levels from dietary intake, or clinical tumor outcomes in humans.

Cited by